32
Participants
Start Date
July 6, 2017
Primary Completion Date
November 21, 2019
Study Completion Date
April 10, 2020
Fulvestrant with Enzalutamide
500mg of Fulvestrant will be given IM on days 1, 15, 28, then every 4 weeks as per standard of care (SOC) and 160mg of Enzalutamide will be given PO daily. Patients will receive a tumor biopsy at the start of treatment and 4 weeks after the start of treatment, with an optional 3rd biopsy at the end treatment.
West Cancer Center, Germantown
University of Colorado, Aurora
Lone Tree Medical Center, Lone Tree
United States Department of Defense
FED
University of Colorado, Denver
OTHER